Gastrointestinal MicrobiomeBLAMNCT06126094
Benefits of Alcoholic Hangover Medicine
A study testing Myrkl and dextrin in people with Gastrointestinal Microbiome, run by The Gut Microbiome Center (Centar za crijevni mikrobiom) at 1 site in Croatia.
Trial summary
Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Gastrointestinal Microbiome
- What is being tested?
- Myrkl and dextrin
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 2 participants
- Where
- 1 siteCroatia
- Study dates
- 31 Oct 2023to 20 Dec 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- fraternal twins who live and work together
Who cannot join
- consumption of other probiotics, antibiotics 30 days before the research
- Inability to drink alcohol
Trial locations and contacts
1 site in 1 country.
Croatia1 site
Gut Microbiome Center
Zagreb, 10000
Andrija Karačić, dr.med, +385981373344, andrija@ccm.hr
Ira Renko, MSC, +385993373343, info@ccm.hr
About this study
Official title: Benefits of Alcoholic Hangover Medicine Myrkl
Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. For this purpose, the research was designed in three phases before, during and after the research as a double blind trial. In doing so, the subjects take a stool sample before and after the intervention and during the intervention, fill out questionnaires and undergo cognitive tests. At the same time, they give a blood sample after the intervention. After the results of the analysis are due, the researchers enter the data into the for that the predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of statistical analysis.
Read the detailed description
A "cure" for an alcoholic hangover has been put on the market, that is, it relieves the symptoms and ailments hangover alcohol (https://www.myrkl.com/). This medicine contains probiotic strains in its formulation (Bacillus subtilis, Bacillus coagulans). Myrkl has been advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. The manufacturer claims that after taking Myrkl participants feel fresh even after a "long night". In addition to the probiotics mentioned above, Myrkl also contains L-cysteine and vitamins B12. The formula is said to be activated in the intestines. The manufacturer states that 77 of users are satisfied product and how it is completely natural. It is recommended to take two capsules two hours before consumption alcohol. With this research, the investigators wanted to determine the taxonomic changes within the intestinal microbiome after the intervention. In addition, the investigators wanted to determine changes in the subjective impression of a hangover measured by a validated questionnaires. The research was designed as a double-blind placebo-controlled intervention study twins (controlled for age, sex, cohabitation, genetics).
Before the start of the intervention, the test subjects will be instructed to eat the same diet during the 48 hours before beginning of each intervention. The subjects will keep a food diary for two days in order to accurately evaluated the nutritional status. The key is that both subjects consume the same food in both times before the intervention. The food intake itself is determined by the respondents independently.
After the intervention, the respondents will fill out a selection of questionnaires created in the form using the link a special online document (Project BLAM, Forms, Microsoft, USA) that will evaluate theirs alcoholic hangover. In order to evaluate the dynamics of the hangover, the test subject will again every 2 hours fill out the questionnaire (6 evaluations in total - waking up, 2, 4, 6, 8 and 10 hours after waking up). The result of each questionnaire is obtained by calculating the arithmetic mean of all answers (0-5, 0-10). Using all questionnaire was approved by the publisher and the English version will be used. Questionnaires were used https://forms.office.com/Pages/DesignPageV2.aspx subpage=design\&FormId=hN0190t4UESOZ73jM ACw9LJ5ROlYHHVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u\&Token=fcda6871a b5d4009b779536b561d8dfb :
- Alcohol Hangover Questionnaire (AHQ)
- Alcohol Hangover Severity Scale (AHSS)
Materials The subject of the test will be supplementation with a precise probiotic for hangovers (Myrkl, De Fair
Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:
- 560 mg of naturally fermented rice bran
- Bacillus subtilis
- B. coagulans
- L-cysteine
- dextrin
- 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate The CFU per strain in the formulation is minimal (ask the manufacturer). The probiotic comes in capsule form blister, stored at room temperature. An 800 mg capsule containing dextrin (maltodextrin) will be used for the placebo. It's a placebo dose also two capsules of 800 mg each.
The recommended intake will be two capsules exactly two hours before alcohol consumption. Control entry will be through a video diary.
Methods Analyzes of the intestinal microbiome Since the impact of probiotics on the intestinal microbiome will be measured before and after the investigated intervention two analyzes of the intestinal microbiome will be carried out on Day 0, i.e. on the day of the start of the intervention and Day 1, the day after the intervention. The BIOMES sampling kit will be used for the analysis, and intest.pro. The analysis will be performed on a sample of the first morning stool that the test subjects will take independently in home conditions Day 0 and Day 1. Samples will be delivered to the company's laboratory by logistics service BOMES (BIOMES GmbH, Wildau, Germany) where next-generation sequencing of 16s will be performed ribosomal RNA and bioinformatic analysis of the results (review of taxonomy and functionality). These results will be delivered to the researchers.
Statistical analysis Statistical data processing will analyze the changes in both test subjects, B1 and B2, taking taking into account whether the intervention was verum (V) or placebo (P). Upon maturity descriptive and inferential statistics will be made of the results using the appropriate program (Statistica, Palo Alto, USA). For normally distributed data, use the Kolmogorov-Smirnoff test will be the average and standard deviation, and for the second group the median and percentiles. To analyze the hypothesis treatment Mann-Whitney test and paired t-test will be used. Statistically significant will be considered p- values less than 0.05.
The research is divided into three phases - before the intervention, intervention, and after interventions. Alcohol is administered during the intervention. The respondents choose the drink they want consumed in two categories: welcome drink - žestice, brandy, liqueur, wormwood, evening drink - gemišt, wine, beer, gin and tonic, juice and juice.
Before intervention:
- the test subjects took the tests and research material at the Sky Office reception
- 48 hours before the intervention, they monitor their diet through a diary
- both test subjects eat absolutely identical food before each intervention
- on Day 0 they take the first stool sample (test A, test C), ideally the morning stool/the first stool
- do not consume any alcohol
- two hours before the planned intervention, say 6:30 p.m., that means around 4:30 p.m. they take a capsule with 1 dl water
Intervention:
- the subjects come to the recording on Day 0 around 18.00 in the CCM area, the conference room
- from 18.00 to 18.30 is preparation for recording
- at 6:30 p.m. the first sip of alcohol follows - a welcome drink (zestica, liqueur)
- around 6:40 p.m. the drinks of the evening follow (gemišt, gin and tonic, beer, wine)
- the first interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
- around 7:00 p.m., the first cut follows - a welcome drink
- around 7:10 p.m., another drink in the evening
- a second conversation follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
- during the second interview, the interviewees have the opportunity to eat something small (meal/sandwich)
- around 19.10 the last drink of the evening goes, possibly. and a welcome drink
- a third interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
- Human Lab takes a blood sample to determine blood ethanol, which CCM employees will take to HKA KBSD same evening immediately
After the intervention:
- after waking up and then within two hours, the subjects fill out the questionnaire: https://forms.office.com/Pages/ResponsePage.aspx?id=hN0190t4UESOZ73jMACw9LJ5ROlYH HVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u
- the morning stool or the first stool after the intervention should be sampled on Day 1
- on Day 1 around 18.00 arrival for filming at the same place
- from 18.00 to 19.00 a conversation about how they feel and whether they think they received a placebo or a probiotic.
After the end of the cycle and the arrival of the results of the analysis, the researchers enter the data into the for that predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of the statistical analysis in the previously explained manner. In these last steps student, research assistants may be involved.
- Conditions
- Gastrointestinal Microbiome
- Being tested
- Myrkl, dextrin
- Keywords
- Microbiota, Probiotics, Alcohol, Cognitive behaviour
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
MyrklDietary supplement
The subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg
dextrinDietary supplement
The subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg)
| Study group | Role | What they receive |
|---|---|---|
| Probiotic | Experimental | Participants will consume 800 mg of probiotic Myrkl before consuming alcohol in the form of one capsule. (Myrkl, De Fair Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:
* 560 mg of naturally fermented rice bran
* Bacillus subtilis
* B. coagulans
* L-cysteine
* dextrin
* 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate Receives: Dietary Supplement: Myrkl |
| Placebo | Experimental | The subject who consumed 800 mg of placebo- dextrin (maltodextrin) in the form of two capsules before consuming alcohol. Receives: Dietary Supplement: dextrin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Gut microbiome composition
The impact of Myrkl on gut microbiome shall assessed through monitoring of relative taxonomic abundance of bacteria that compose gut microbiota from samples taken day before the intervention and after the intervention.
The composition of the intestinal microbiota will be determined by sequencing the 16s rRNA bacteria in the stool sample. Subjects take a sample with a sterile cotton swab by wiping stool with toilet paper in their home on a given day research. The sample is stored in a tube with a buffer liquid so that the sample can be stored and transported at room temperature temperature. The test sample is transported by air to the laboratory of Biomes NGS Gesellschaft mit beschränkter Haftung, Wildau, Germany.
Measured: one month
Secondary outcomes (1)
the subjective impression of a hangover
In order to validate the subjective impression of a hangover, the subjects will fill out the Alcohol Hangover Questionnaire (AHQ) several times.
Measured: one month
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 Nov 2023
- Study start31 Oct 2023 (estimated)
- Primary completion1 Dec 2023 (estimated)
- Study completion20 Dec 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Gastrointestinal MicrobiomeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Model description
- The test subjects receive capsules of probiotics and palcebo in marked bags and take one or the other arbitrarily without being told what is in which bag. Likewise, the researchers do not know whether the subjects took the probiotic or the placebo.
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 2 participants (estimated)
Sponsor and investigators
- Lead sponsor
- The Gut Microbiome Center (Centar za crijevni mikrobiom)
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Andrija Karačić, dr.med, Study director, Centar za crijevni mikrobiom
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT06126094
- Sponsor's protocol ID
- BLAM123
- Acronym
- BLAM
- Status last verified
- Oct 2023
- First submitted
- 31 Oct 2023
- Last updated
- 13 Nov 2023
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 13 Nov 2023. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Benefits of Alcoholic Hangover Medicine Myrkl
- ClinicalTrials.gov ID
- NCT06126094
- Acronym / sponsor ID
- BLAM / BLAM123
- Conditions
- Gastrointestinal Microbiome
- Keywords
- Microbiota, Probiotics, Alcohol, Cognitive behaviour
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 2 participants (estimated)
- Lead sponsor
- The Gut Microbiome Center (Centar za crijevni mikrobiom)University, hospital or other
- Study start
- 31 Oct 2023 (estimated)
- Primary completion
- 1 Dec 2023 (estimated)
- Study completion
- 20 Dec 2023 (estimated)
- First posted
- 13 Nov 2023 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Myrkl is advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. With this research, the investigators want to determine the impact of the mentioned dietary supplement on the intestinal microbiome. For this purpose, the research was designed in three phases before, during and after the research as a double blind trial. In doing so, the subjects take a stool sample before and after the intervention and during the intervention, fill out questionnaires and undergo cognitive tests. At the same time, they give a blood sample after the intervention. After the results of the analysis are due, the researchers enter the data into the for that the predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of statistical analysis.
Detailed description
A "cure" for an alcoholic hangover has been put on the market, that is, it relieves the symptoms and ailments hangover alcohol (https://www.myrkl.com/). This medicine contains probiotic strains in its formulation (Bacillus subtilis, Bacillus coagulans). Myrkl has been advertised as a dietary supplement for use before alcohol consumption that is effective in prevention of side effects during the next day. The manufacturer claims that after taking Myrkl participants feel fresh even after a "long night". In addition to the probiotics mentioned above, Myrkl also contains L-cysteine and vitamins B12. The formula is said to be activated in the intestines. The manufacturer states that 77 of users are satisfied product and how it is completely natural. It is recommended to take two capsules two hours before consumption alcohol. With this research, the investigators wanted to determine the taxonomic changes within the intestinal microbiome after the intervention. In addition, the investigators wanted to determine changes in the subjective impression of a hangover measured by a validated questionnaires. The research was designed as a double-blind placebo-controlled intervention study twins (controlled for age, sex, cohabitation, genetics).
Before the start of the intervention, the test subjects will be instructed to eat the same diet during the 48 hours before beginning of each intervention. The subjects will keep a food diary for two days in order to accurately evaluated the nutritional status. The key is that both subjects consume the same food in both times before the intervention. The food intake itself is determined by the respondents independently.
After the intervention, the respondents will fill out a selection of questionnaires created in the form using the link a special online document (Project BLAM, Forms, Microsoft, USA) that will evaluate theirs alcoholic hangover. In order to evaluate the dynamics of the hangover, the test subject will again every 2 hours fill out the questionnaire (6 evaluations in total - waking up, 2, 4, 6, 8 and 10 hours after waking up). The result of each questionnaire is obtained by calculating the arithmetic mean of all answers (0-5, 0-10). Using all questionnaire was approved by the publisher and the English version will be used. Questionnaires were used https://forms.office.com/Pages/DesignPageV2.aspx subpage=design\&FormId=hN0190t4UESOZ73jM ACw9LJ5ROlYHHVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u\&Token=fcda6871a b5d4009b779536b561d8dfb :
- Alcohol Hangover Questionnaire (AHQ)
- Alcohol Hangover Severity Scale (AHSS)
Materials The subject of the test will be supplementation with a precise probiotic for hangovers (Myrkl, De Fair
Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of:
- 560 mg of naturally fermented rice bran
- Bacillus subtilis
- B. coagulans
- L-cysteine
- dextrin
- 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate The CFU per strain in the formulation is minimal (ask the manufacturer). The probiotic comes in capsule form blister, stored at room temperature. An 800 mg capsule containing dextrin (maltodextrin) will be used for the placebo. It's a placebo dose also two capsules of 800 mg each.
The recommended intake will be two capsules exactly two hours before alcohol consumption. Control entry will be through a video diary.
Methods Analyzes of the intestinal microbiome Since the impact of probiotics on the intestinal microbiome will be measured before and after the investigated intervention two analyzes of the intestinal microbiome will be carried out on Day 0, i.e. on the day of the start of the intervention and Day 1, the day after the intervention. The BIOMES sampling kit will be used for the analysis, and intest.pro. The analysis will be performed on a sample of the first morning stool that the test subjects will take independently in home conditions Day 0 and Day 1. Samples will be delivered to the company's laboratory by logistics service BOMES (BIOMES GmbH, Wildau, Germany) where next-generation sequencing of 16s will be performed ribosomal RNA and bioinformatic analysis of the results (review of taxonomy and functionality). These results will be delivered to the researchers.
Statistical analysis Statistical data processing will analyze the changes in both test subjects, B1 and B2, taking taking into account whether the intervention was verum (V) or placebo (P). Upon maturity descriptive and inferential statistics will be made of the results using the appropriate program (Statistica, Palo Alto, USA). For normally distributed data, use the Kolmogorov-Smirnoff test will be the average and standard deviation, and for the second group the median and percentiles. To analyze the hypothesis treatment Mann-Whitney test and paired t-test will be used. Statistically significant will be considered p- values less than 0.05.
The research is divided into three phases - before the intervention, intervention, and after interventions. Alcohol is administered during the intervention. The respondents choose the drink they want consumed in two categories: welcome drink - žestice, brandy, liqueur, wormwood, evening drink - gemišt, wine, beer, gin and tonic, juice and juice.
Before intervention:
- the test subjects took the tests and research material at the Sky Office reception
- 48 hours before the intervention, they monitor their diet through a diary
- both test subjects eat absolutely identical food before each intervention
- on Day 0 they take the first stool sample (test A, test C), ideally the morning stool/the first stool
- do not consume any alcohol
- two hours before the planned intervention, say 6:30 p.m., that means around 4:30 p.m. they take a capsule with 1 dl water
Intervention:
- the subjects come to the recording on Day 0 around 18.00 in the CCM area, the conference room
- from 18.00 to 18.30 is preparation for recording
- at 6:30 p.m. the first sip of alcohol follows - a welcome drink (zestica, liqueur)
- around 6:40 p.m. the drinks of the evening follow (gemišt, gin and tonic, beer, wine)
- the first interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
- around 7:00 p.m., the first cut follows - a welcome drink
- around 7:10 p.m., another drink in the evening
- a second conversation follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
- during the second interview, the interviewees have the opportunity to eat something small (meal/sandwich)
- around 19.10 the last drink of the evening goes, possibly. and a welcome drink
- a third interview follows in terms of checking the degree of intoxication (cognitive tests 1-25/quiz)
- Human Lab takes a blood sample to determine blood ethanol, which CCM employees will take to HKA KBSD same evening immediately
After the intervention:
- after waking up and then within two hours, the subjects fill out the questionnaire: https://forms.office.com/Pages/ResponsePage.aspx?id=hN0190t4UESOZ73jMACw9LJ5ROlYH HVMuwYZ6ti3GaRUOEZEUVhSNDlPVjMwT1ZJVUFWTjQ3QldYRC4u
- the morning stool or the first stool after the intervention should be sampled on Day 1
- on Day 1 around 18.00 arrival for filming at the same place
- from 18.00 to 19.00 a conversation about how they feel and whether they think they received a placebo or a probiotic.
After the end of the cycle and the arrival of the results of the analysis, the researchers enter the data into the for that predicted Access table (rel. representation of genera/genera/species, average results by questionnaires). The entered data is processed as part of the statistical analysis in the previously explained manner. In these last steps student, research assistants may be involved.
Study design
- Primary purpose
- Basic science
- Allocation
- Non-randomised
- Intervention model
- Crossover
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
- Model description
- The test subjects receive capsules of probiotics and palcebo in marked bags and take one or the other arbitrarily without being told what is in which bag. Likewise, the researchers do not know whether the subjects took the probiotic or the placebo.
| Arm | Type | Receives |
|---|---|---|
| Probiotic | Experimental | Dietary Supplement: MyrklParticipants will consume 800 mg of probiotic Myrkl before consuming alcohol in the form of one capsule. (Myrkl, De Fair Medical, Stockholm, Sweden). This formulation contains AB001™, and one capsule (800mg) consists of: * 560 mg of naturally fermented rice bran * Bacillus subtilis * B. coagulans * L-cysteine * dextrin * 36 mg of excipients: magnesium stearate salts, calcium phosphate, potassium phosphate |
| Placebo | Experimental | Dietary Supplement: dextrinThe subject who consumed 800 mg of placebo- dextrin (maltodextrin) in the form of two capsules before consuming alcohol. |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (1 listed)
- fraternal twins who live and work together
Key exclusion criteria (2 listed)
- consumption of other probiotics, antibiotics 30 days before the research
- Inability to drink alcohol
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| MyrklThe subject of the test will be supplementation with precise probiotic for hangovers (Myrkl, De Fair) in the form of one pill of 800 mg | Dietary supplement | Probiotic |
| dextrinThe subject of the test will be supplementation with placebo (maltodextrin) in the form of two pills (each 400 mg) | Dietary supplement | Placebo |
Primary outcome
Gut microbiome composition
Time frame: one month
The impact of Myrkl on gut microbiome shall assessed through monitoring of relative taxonomic abundance of bacteria that compose gut microbiota from samples taken day before the intervention and after the intervention. The composition of the intestinal microbiota will be determined by sequencing the 16s rRNA bacteria in the stool sample. Subjects take a sample with a sterile cotton swab by wiping stool with toilet paper in their home on a given day research. The sample is stored in a tube with a buffer liquid so that the sample can be stored and transported at room temperature temperature. The test sample is transported by air to the laboratory of Biomes NGS Gesellschaft mit beschränkter Haftung, Wildau, Germany.
1 secondary outcome
the subjective impression of a hangover
Time frame: one month
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 13 Nov 2023.
- Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover StudyLink provided by the sponsor.
- Chronic Uptake of A Probiotic Nutritional Supplement (AB001) Inhibits Absorption of Ethylalcohol in the Intestine Tract - Results from a Randomized Double-blind Crossover StudyLink provided by the sponsor.
- Individual participant dataSharing planned: No
Related trials for Gastrointestinal Microbiome
Recruiting
Colon-delivered Riboflavin and Gut Microbiota Composition
Microbiome Dysbiosis, Gut Health
Active, not recruiting
Effect of Probiotics on Insulin Sensitivity in Overweight and Obese Pregnancy
Obesity & Overweight, Gestational Diabetes Mellitus (GDM)
Active, not recruiting
SweetSpot - The Effect of Non-nutritive Sweeteners on Health
Healthy Adult
Enrolling by invitation
Dance-Based Exercise for Cancer-Related Fatigue in Breast Cancer Patients
Breast Neoplasms
Recruiting
The Effect of a Synbiotic on Intestinal Barrier Function and Microbiota Modulation in Middle-aged to Elderly Individuals
Gastrointestinal Microbiome (Focus), Gastrointestinal Symptoms
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andrija Karačić, dr.med study director
Centar za crijevni mikrobiom
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Myrkl and dextrin in people with Gastrointestinal Microbiome, run by The Gut Microbiome Center (Centar za crijevni mikrobiom) at 1 site in Croatia.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 13 Nov 2023. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Croatia. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
Contact Andrija Karačić, dr.med (+385981373344, andrija@ccm.hr), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Gut microbiome composition (time frame: one month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Nov 2023.